ADMA Biologics ADMA Plasma Collection Centers — Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's plasma collection centers — nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's plasma collection centers — nonoperating income expense?
- ADMA Biologics (ADMA) reported plasma collection centers — nonoperating income expense of $68K in Q1 2026.
- What does plasma collection centers — nonoperating income expense mean?
- Includes financial items not related to the core plasma collection operations, such as interest income, interest expense, or foreign exchange gains and losses. This metric isolates the impact of financing and peripheral activities from the segment's primary business performance. It is essential for understanding the segment's net contribution to the company's bottom line.